| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H2036 |
Alcohol and/or other drug treatment program, per diem |
57,781 |
4,698 |
$15.30M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
340 |
226 |
$36K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
566 |
347 |
$22K |
| 86803 |
|
1,065 |
911 |
$11K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
531 |
452 |
$9K |
| 87340 |
|
1,079 |
936 |
$8K |
| 87522 |
Neg quan hep c or qual rna |
189 |
167 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
72 |
36 |
$5K |
| 86706 |
|
505 |
478 |
$4K |
| 80053 |
Comprehensive metabolic panel |
478 |
386 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
498 |
391 |
$3K |
| 83735 |
|
548 |
443 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
219 |
155 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
242 |
177 |
$2K |
| 84100 |
|
516 |
415 |
$2K |
| 82248 |
|
474 |
382 |
$2K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
338 |
310 |
$0.00 |